Cafage-XP 250mg/31.25mg Injection
Marketer
Allenge India
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cafage-XP 250mg/31.25mg Injection
Xpacifin 250mg/31.25mg Injection, a dual-action antibiotic, is indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby controlling infection spread. Administration of Xpacifin 250mg/31.25mg Injection must be under a physician's guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course is essential, even with symptom improvement. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (e.g., skin rashes, pruritus, edema, dyspnea) demand prompt emergency care. Prior to commencing treatment, inform your physician of all current medications and pre-existing conditions. Pregnant or lactating individuals require specific consultation. Alcohol consumption should be avoided due to potential increased somnolence. While generally non-impairing to driving ability, drowsiness or dizziness mandates driving cessation. Adequate rest, a balanced diet, and sufficient hydration promote optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Uses of Cafage-XP 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cafage-XP 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cafage-XP 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cafage-XP 250mg/31.25mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Cafage-XP 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum Injection (Cafage-XP 250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactum counters bacterial resistance, thereby boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cafage-XP 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cafage-XP (250mg/31.25mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Cafage-XP 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Cafage-XP 250mg/31.25mg Injection can lead to reduced awareness, impaired vision, drowsiness, and dizziness. Operation of a vehicle is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cafage-XP 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Cafage-XP (250mg/31.25mg) requires careful administration in individuals with significant hepatic impairment, potentially necessitating dose modification. Medical consultation is advised. Dosage alteration for Cafage-XP (250mg/31.25mg) injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cafage-XP 250mg/31.25mg Injection :
Should you omit a scheduled dose of Cafage-XP 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Cafage-XP 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently